Clinical Trial Update: Optimalization of Nephroprotection Using Atorvastatin (Sortis) [NA]

View source ↗

Summary

A completed clinical trial evaluated whether atorvastatin (Sortis) offers kidney-protective effects in patients with chronic kidney disease and proteinuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Sortis (atorvastatin)

Snippet

Sponsor: Medical University of Gdansk | Conditions: Chronic Kidney Disease, Proteinuria | NA | Status: COMPLETED